Company Data
Clene Inc.
Ticker
CLNN
Current Price
$4.81 5.48%
Market Cap
$38.4M
Price Target
Refer to Report
Volume
52.9K
52wk Range
$3.8181 - $10.646
Overview
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements).